Koers Chalice Brands Ltd. Canadian Securities Exchange
Aandelen
CHAL
CA15756R1047
Farmaceutische producten
Omzet 2019 | 15,75 mln. 21,54 mln. 14,45 mln. | Omzet 2020 | 21,91 mln. 29,95 mln. 20,1 mln. | Marktkapitalisatie | 20,07 mln. 27,44 mln. 18,41 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -46 mln. -62,89 mln. -42,2 mln. | Nettowinst (verlies) 2020 | -10 mln. -13,67 mln. -9,17 mln. | EV/omzet 2019 | 1,28 x |
Nettoschuld 2019 | 6,22 mln. 8,51 mln. 5,71 mln. | Nettoschuld 2020 | 10,27 mln. 14,04 mln. 9,42 mln. | EV/omzet 2020 | 1,38 x |
K/w-verhouding 2019 |
-0,23
x | K/w-verhouding 2020 |
-1,89
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 78,85% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,94% | 4,99 mld. | |
-32,21% | 3,61 mld. | |
-1,43% | 3,1 mld. | |
-25,09% | 2,64 mld. | |
-11,46% | 2,32 mld. | |
+36,65% | 1,85 mld. | |
+37,15% | 1,43 mld. | |
-16,01% | 1,39 mld. | |
+40,95% | 1,37 mld. |